A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects.
about
P1343
Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent mannerProtein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein TatPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for functionAn RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activationThe regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapseSodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachmentPalmitic acid analogs exhibit nanomolar binding affinity for the HIV-1 CD4 receptor and nanomolar inhibition of gp120-to-CD4 fusionThe anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization.Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assayDiscovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.Identification of X-DING-CD4, a new member of human DING protein family that is secreted by HIV-1 resistant CD4(+) T cells and has anti-viral activity.Pokeweed antiviral protein increases HIV-1 particle infectivity by activating the cellular mitogen activated protein kinase pathway.CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcriptionInhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme.APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study.DING proteins from phylogenetically different species share high degrees of sequence and structure homology and block transcription of HIV-1 LTR promoter.Human X-DING-CD4 mediates resistance to HIV-1 infection through novel paracrine-like signaling.Specific marking of HIV-1 positive cells using a Rev-dependent lentiviral vector expressing the green fluorescent protein.An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.Apoptosis-induced activation of HIV-1 in latently infected cell linesRepression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism.IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancerThe critical role of human transcriptional repressor CTCF mRNA up-regulation in the induction of anti-HIV-1 responses in CD4(+) T cellsRev-dependent indicator T cell lineThe BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.Neisseria gonorrhoeae-derived heptose elicits an innate immune response and drives HIV-1 expressionBCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complexIdentification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation.The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domainMeasurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates.
P2860
Q24301811-9563EA1A-9C4B-44C9-A7AD-611C16B9930CQ24311873-832C7168-A5C9-486D-A252-FBC174BB3D78Q24523183-FD8FE3B0-821E-4F74-BC2B-867E17DE1FB1Q24682531-BD564684-3E56-4B8C-B412-50A3DAD569A9Q24685792-F00A2E8E-FC56-4547-8CFB-522DE1639A9FQ27349077-6C24AA24-A2A6-472B-8FF5-2011E4D51E97Q28343806-4D37F176-2077-4167-A147-D72E53FB3D14Q28475112-F8A2AD7E-15DB-417E-942E-478482B68A5AQ28546013-6F261A52-6E05-40C2-948E-5495BD7419FAQ30654626-9C6A8F35-5E2D-4678-9FBD-E90F32E9835DQ33404066-7E1A3A3D-C164-4329-B2FF-97DBE576E313Q33743857-7C0FA5BD-19EA-4739-8F8A-36AFB40AEABCQ33782387-71D29B54-C817-412E-BE16-F139EBBBBFB6Q33783773-DDDC6D1B-AEE0-4BC0-BC0C-C2F193B67D6BQ33792536-C48DBE70-CB88-42C5-B7F3-CE7077864CD0Q34090863-D11184EC-BEE8-41D4-ADB9-9D0E24B20623Q34215448-42F0751A-2362-4DAE-9265-5CD8DE35E15AQ34260135-6DF0C05F-93F7-4ECF-83D6-13CCF12A290DQ34585299-5986BC91-ABC9-4DA0-9FDB-411E57FAF561Q34691336-156AF91B-2E18-4D2E-946A-AA3F54133323Q34749384-1B645868-1695-4869-8EB4-1743C9DBF79CQ34924514-A055D2BE-F873-429D-A1E2-13E0630C16ECQ35151991-0BCDF138-B88D-4356-90E3-9B628CF2DF22Q35588311-A0961340-B942-4C5C-AA3E-BC48B0AEAADDQ35607410-F71C1D8A-1594-470C-ADF1-4109F8D1C04CQ35747595-A43FA69F-6B33-4732-B3E2-7CFD3078400FQ35862050-2C39CD3D-C245-4ED3-A81F-1B36AAD55BA9Q35882741-6E047762-7005-467B-A099-BC858616B3C1Q36082720-6489112A-A1BE-48DF-B69C-42D891520B01Q36353497-DF4B7B09-5143-456F-BAAB-5AE229F1BF38Q36498248-932998CA-8268-4893-9AC5-B79E1C32108CQ36594233-41A89D18-1902-473F-9FE6-0D87FC65E684Q36629200-2FCA15E2-89BB-404E-97B1-D872EBE42CEAQ36668708-652F5CAB-70F5-4238-A75C-A7596A7DE6B8Q36950468-05C2357D-DDF7-4261-A66D-A8D7C7BCF75CQ37088793-BB913D40-F8F1-455B-831B-0C2276B89F27Q37157165-695940B7-C926-4592-BE95-EEBEECD36FE7Q37196566-E3ED55A8-F45D-4979-BD58-7DADF5A1F31CQ37333789-73B4A9FC-A09D-4888-AB6C-1ADA2F96A7ADQ37333866-A0DC30B8-E208-45B1-90E8-A66B33B296A8
P2860
A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
A sensitive reporter cell line ...... and T cell activation effects.
@en
type
label
A sensitive reporter cell line ...... and T cell activation effects.
@en
prefLabel
A sensitive reporter cell line ...... and T cell activation effects.
@en
P2093
P356
P1476
A sensitive reporter cell line ...... and T cell activation effects.
@en
P2093
Aguilar-Cordova E
Belmont JW
Donehower L
P304
P356
10.1089/AID.1994.10.295
P4510
P577
1994-03-01T00:00:00Z